Search
for
Sort by
Research 151–180 of 1000+
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Efficacy and safety of dual-targeted therapy for refractory inflammatory bowel disease: a retrospective case series from three tertiary general hospitals in China
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- This Week in JAMA
- Violeta de genciana no tratamento terapêutico de malasseziose felina refratária
- Management of hair loss diseases
- Resting no more: re‐defining telogen, the maintenance stage of the hair growth cycle
- Platelet-rich plasma: The journey so far !
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Skin manifestations of Bardet–Biedl syndrome
- Medical Dermatology
- The effects of hair regrowth with intravenous immunoglobulin (IVIG) therapy. Two case reports
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Enhancing Hair Regrowth in Pediatric Morphea en Coup de Sabre by Fractional CO<sub>2</sub> Laser‐Assisted Exosome Delivery
- Editor's Picks
- A Very Bad Hair Day: Minoxidil Ingestion Causing Shock and Heart Failure
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Abstract 13315: Recurrent Cardiac Tamponade Due to Minoxidil Associated Drug Induced Lupus Erythematosus
- Immune globulin
- Dissecting cellulitis of the scalp successfully treated with infliximab
- VP-16-213 (etoposide): The mandrake root from Issyk-Kul
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- A Case Report of Cronkhite-Canada Syndrome Complicated by Membranous Nephropathy
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances
- Epilepsy and Neurodegeneration: Clues in the Hair and Blood Vessels!
- Deucravacitinib in dermatology: current indication and existing off-label data
- Novel drugs of United States Food and Drug Administration approved in 2024
- Supplementary Material for: Drug-Induced Melasma in Patients on 5-Alpha Reductase Inhibitors: A Case Report
- P142 – 3046: Encephalocraniocutaneous lipomatosis, a rare neurocutaneous disorder: Report of additional three cases